Understanding Severe MTHFR Deficiency
At a Glance
Severe MTHFR deficiency is a rare inherited disorder that causes very high homocysteine and low or normal methionine. Metabolic specialists treat it mainly with betaine, carefully selected B vitamins, and sometimes methionine, with regular monitoring.
If you have just received a diagnosis of severe MTHFR deficiency, you are likely feeling a mix of shock, confusion, and perhaps a sense of isolation. This condition is profoundly different from the “MTHFR mutations” often discussed in wellness blogs or social media. While many people carry common genetic variations that might slightly affect how they process folate, your family is dealing with a rare, serious metabolic disorder that requires specialized medical management [1][2].
Understanding the “Severe” Difference
The MTHFR gene provides instructions for making an enzyme called methylenetetrahydrofolate reductase. This enzyme is a critical part of a process called remethylation, where the body converts a potentially harmful amino acid called homocysteine into a necessary one called methionine [3].
Most of the “MTHFR” talk online refers to common polymorphisms (like C677T or A1298C), which are found in up to half the population and usually have little to no clinical impact [4][1]. In contrast, severe MTHFR deficiency is an extremely rare autosomal recessive disorder [1]. This means a person has inherited pathogenic variants in both copies of the gene, resulting in an enzyme that works poorly or not at all [5][6].
Why It Is So Rare
Severe MTHFR deficiency is one of the rarest metabolic conditions. To understand just how rare it is: an Irish report estimated a prevalence of about 0.08 cases per 100,000 people in the Republic of Ireland [7]. In a separate newborn screening cohort in Zibo, out of 84,722 neonates screened, only one child was identified with the condition [8].
Because it is so rare, many general practitioners may have never seen a case. Your care will typically be led by a metabolic geneticist—a specialist who understands the complex chemistry of how your body breaks down and utilizes nutrients.
The Biochemical Pattern
In severe MTHFR deficiency, the impairment in the remethylation process leads to a specific signature in the blood:
- Severe Hyperhomocysteinemia: Very high levels of homocysteine. Without the MTHFR enzyme to convert it, homocysteine builds up to levels that can be toxic to the brain and blood vessels [9][10].
- Low or Normal Methionine: Because the conversion process is broken, the body cannot produce enough methionine, an amino acid essential for growth and brain function [3][11].
This pattern is the opposite of other forms of homocystinuria (like CBS deficiency), where methionine is usually high. This distinction is critical because it changes how the disease is treated [3].
A Spectrum of Symptoms
The symptoms of severe MTHFR deficiency can vary widely based on how much enzyme activity a person has.
- Early-Onset (Infantile): Often appearing in the first few months of life. Babies may have trouble feeding, experience seizures, have small head sizes (microcephaly), or seem unusually floppy (hypotonia) [12][13].
- Late-Onset (Childhood or Adult): Some people present later with developmental delays, psychiatric symptoms, or problems with walking and coordination (ataxia) [9].
Standard Medical Management
The goal of treatment is to lower homocysteine and raise methionine as close to normal levels as achievable [3]. While your specialist will create a customized plan, the following are standard interventions:
- Betaine Anhydrous: This is a core, disease-specific treatment [3]. It provides an alternative route for the body to clear homocysteine. It is most effective when started early [14][15].
- B-Vitamins: Specialists may use specific forms of folate (like 5-MTHF or folinic acid) and vitamin B12 (hydroxocobalamin). High-dose supplements must never be started or adjusted without the metabolic team [3][16].
- Methionine Supplementation: If blood levels of methionine are dangerously low, your doctor may add strictly monitored methionine supplements [9][2].
Because this is a lifelong genetic condition, it is highly recommended to seek genetic counseling to understand the risks for future pregnancies, carrier testing for siblings, and family planning options.
Glossary of Terms
- Total Homocysteine (tHcy): An amino acid in the blood that builds up when remethylation is impaired.
- Methionine: An essential amino acid normally produced from homocysteine.
- MMA (Methylmalonic Acid): A marker used to help differentiate B12 defects.
- Autosomal Recessive: Inheriting two mutated copies of a gene, one from each parent.
Common questions in this guide
What is severe MTHFR deficiency homocystinuria?
How is severe MTHFR deficiency different from common MTHFR variants?
What blood test pattern suggests severe MTHFR deficiency?
What symptoms can severe MTHFR deficiency cause?
How is severe MTHFR deficiency treated?
Does severe MTHFR deficiency run in families?
Get notified when new evidence is published on Homocystinuria due to methylene tetrahydrofolate reductase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
MTHFR: Addressing Genetic Counseling Dilemmas Using Evidence-Based Literature.
Levin BL, Varga E
Journal of genetic counseling 2016; (25(5)):901-11 doi:10.1007/s10897-016-9956-7.
PMID: 27130656 - 2
Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency.
Rommer PS, Zschocke J, Fowler B, et al.
Journal of the neurological sciences 2017; (383()):123-127 doi:10.1016/j.jns.2017.10.035.
PMID: 29246599 - 3
First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.
Olivieri G, Bordugo A, Burnyte B, et al.
Journal of inherited metabolic disease 2026; (49(4)):e70177 doi:10.1002/jimd.70177.
PMID: 42231716 - 4
Shifting landscapes of human MTHFR missense-variant effects.
Weile J, Kishore N, Sun S, et al.
American journal of human genetics 2021; (108(7)):1283-1300 doi:10.1016/j.ajhg.2021.05.009.
PMID: 34214447 - 5
Development of a novel liquid chromatography-tandem mass spectrometry based enzymatic assay of 5,10-methylenetetrahydrofolate reductase.
Sunoki K, Watanabe M, Aoki S, et al.
Scientific reports 2025; (15(1)):22674.
PMID: 40596302 - 6
Insights into severe 5,10-methylenetetrahydrofolate reductase deficiency: molecular genetic and enzymatic characterization of 76 patients.
Burda P, Schäfer A, Suormala T, et al.
Human mutation 2015; (36(6)):611-21 doi:10.1002/humu.22779.
PMID: 25736335 - 7
Expanding the Phenotypic Spectrum of Methylenetetrahydrofolate Reductase (MTHFR) Deficiency in Childhood: A Case Series.
Loftus E, Elbishari Z, Fitzsimons P, et al.
Clinical case reports 2025; (13(7)):e9660 doi:10.1002/ccr3.9660.
PMID: 40575625 - 8
High incidence of maternal vitamin B12 deficiency detected by newborn screening: first results from a study for the evaluation of 26 additional target disorders for the German newborn screening panel.
Gramer G, Fang-Hoffmann J, Feyh P, et al.
World journal of pediatrics : WJP 2018; (14(5)):470-481 doi:10.1007/s12519-018-0159-1.
PMID: 29948967 - 9
Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency.
Huemer M, Mulder-Bleile R, Burda P, et al.
Journal of inherited metabolic disease 2016; (39(1)):115-24 doi:10.1007/s10545-015-9860-6.
PMID: 26025547 - 10
Contribution of Genetic Test to Early Diagnosis of Methylenetetrahydrofolate Reductase (MTHFR) Deficiency: The Experience of a Reference Center in Southern Italy.
Barretta F, Uomo F, Fecarotta S, et al.
Genes 2023; (14(5)) doi:10.3390/genes14050980.
PMID: 37239340 - 11
Homocysteinemia due to MTHFR deficiency in a young adult presenting with bilateral lens subluxations.
Couser NL, McClure J, Evans MW, et al.
Ophthalmic genetics 2017; (38(1)):91-94 doi:10.3109/13816810.2016.1143017.
PMID: 27046515 - 12
Variable neurological phenotypes of homocystinuria caused by biallelic methylenetetrahydrofolate reductase variants.
Moirangthem A, Saxena D, Masih S, et al.
Clinical dysmorphology 2022; (31(2)):59-65 doi:10.1097/MCD.0000000000000407.
PMID: 34845156 - 13
Influence of early identification and therapy on long-term outcomes in early-onset MTHFR deficiency.
Yverneau M, Leroux S, Imbard A, et al.
Journal of inherited metabolic disease 2022; (45(4)):848-861 doi:10.1002/jimd.12504.
PMID: 35460084 - 14
Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.
Huemer M, Diodato D, Schwahn B, et al.
Journal of inherited metabolic disease 2017; (40(1)):21-48 doi:10.1007/s10545-016-9991-4.
PMID: 27905001 - 15
Betaine anhydrous in homocystinuria: results from the RoCH registry.
Valayannopoulos V, Schiff M, Guffon N, et al.
Orphanet journal of rare diseases 2019; (14(1)):66 doi:10.1186/s13023-019-1036-2.
PMID: 30871635 - 16
Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.
Knowles L, Morris AA, Walter JH
JIMD reports 2016; (29()):103-107 doi:10.1007/8904_2016_529.
PMID: 26898294
This page is for informational purposes only and does not replace medical advice. A metabolic geneticist should interpret your homocysteine, methionine, and genetic results and guide any betaine, vitamin, or methionine treatment.